Literature DB >> 28912576

Interrogating open issues in cancer medicine with patient-derived xenografts.

Annette T Byrne, Denis G Alférez, Frédéric Amant, Daniela Annibali, Joaquín Arribas, Andrew V Biankin, Alejandra Bruna, Eva Budinská, Carlos Caldas, David K Chang, Robert B Clarke, Hans Clevers, George Coukos, Virginie Dangles-Marie, S Gail Eckhardt, Eva Gonzalez-Suarez, Els Hermans, Manuel Hidalgo, Monika A Jarzabek, Steven de Jong, Jos Jonkers, Kristel Kemper, Luisa Lanfrancone, Gunhild Mari Mælandsmo, Elisabetta Marangoni, Jean-Christophe Marine, Enzo Medico, Jens Henrik Norum, Héctor G Palmer, Daniel S Peeper, Pier Giuseppe Pelicci, Alejandro Piris-Gimenez, Sergio Roman-Roman, Oscar M Rueda, Joan Seoane, Violeta Serra, Laura Soucek, Dominique Vanhecke, Alberto Villanueva, Emilie Vinolo, Andrea Bertotti, Livio Trusolino.   

Abstract

This corrects the article DOI: 10.1038/nrc.2016.140.

Entities:  

Year:  2017        PMID: 28912576     DOI: 10.1038/nrc.2017.85

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  14 in total

Review 1.  Cancer metabolism gets physical.

Authors:  Peter DelNero; Benjamin D Hopkins; Lewis C Cantley; Claudia Fischbach
Journal:  Sci Transl Med       Date:  2018-05-23       Impact factor: 17.956

2.  Personalized therapeutic strategies in HER2-driven gastric cancer.

Authors:  Stefano Ughetto; Cristina Migliore; Simona Corso; Silvia Giordano; Filippo Pietrantonio; Maria Apicella; Annalisa Petrelli; Laura D'Errico; Stefania Durando; Daniel Moya-Rull; Sara E Bellomo; Sabrina Rizzolio; Tania Capelôa; Salvatore Ribisi; Maurizio Degiuli; Rossella Reddavid; Ida Rapa; Uberto Fumagalli; Stefano De Pascale; Dario Ribero; Carla Baronchelli; Giovanni Sgroi; Emanuele Rausa; Gian Luca Baiocchi; Sarah Molfino; Stefania Manenti; Maria Bencivenga; Michele Sacco; Claudia Castelli; Salvatore Siena; Andrea Sartore-Bianchi; Federica Tosi; Federica Morano; Alessandra Raimondi; Michele Prisciandaro; Annunziata Gloghini; Silvia Marsoni; Antonino Sottile; Ivana Sarotto; Anna Sapino; Caterina Marchiò; Paola Cassoni; Simonetta Guarrera
Journal:  Gastric Cancer       Date:  2021-03-23       Impact factor: 7.370

Review 3.  Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations.

Authors:  Anthony Letai; Patrick Bhola; Alana L Welm
Journal:  Cancer Cell       Date:  2021-12-23       Impact factor: 31.743

Review 4.  Organoid technology and applications in cancer research.

Authors:  Hanxiao Xu; Xiaodong Lyu; Ming Yi; Weiheng Zhao; Yongping Song; Kongming Wu
Journal:  J Hematol Oncol       Date:  2018-09-15       Impact factor: 17.388

5.  Implementing Patient-Derived Xenografts to Assess the Effectiveness of Cyclin-Dependent Kinase Inhibitors in Glioblastoma.

Authors:  Janis J Noonan; Monika Jarzabek; Frank A Lincoln; Brenton L Cavanagh; Arhona R Pariag; Viktorija Juric; Leonie S Young; Keith L Ligon; Hanne Jahns; Daniella Zheleva; Jochen H M Prehn; Markus Rehm; Annette T Byrne; Brona M Murphy
Journal:  Cancers (Basel)       Date:  2019-12-12       Impact factor: 6.639

Review 6.  Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research.

Authors:  Nicole Dünker; Verena Jendrossek
Journal:  Cancers (Basel)       Date:  2019-10-07       Impact factor: 6.639

7.  Anti-angiogenic drug scheduling optimisation with application to colorectal cancer.

Authors:  M Sturrock; I S Miller; G Kang; N Hannis Arba'ie; A C O'Farrell; A Barat; G Marston; P L Coletta; A T Byrne; J H Prehn
Journal:  Sci Rep       Date:  2018-07-25       Impact factor: 4.379

Review 8.  Progress in the application of organoids to breast cancer research.

Authors:  Liping Yang; Baoer Liu; Haodong Chen; Rui Gao; Kanghua Huang; Qiuyi Guo; Feng Li; Weicai Chen; Jinsong He
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

9.  The ongoing trends of patient-derived xenograft models in oncology.

Authors:  Jianyong Zhuo; Renyi Su; Winyen Tan; Zhengxing Lian; Di Lu; Xiao Xu
Journal:  Cancer Commun (Lond)       Date:  2020-09-20

10.  Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers.

Authors:  Gerardo Colon-Otero; Valentina Zanfagnin; Xiaonan Hou; Nathan R Foster; Erik J Asmus; Andrea Wahner Hendrickson; Aminah Jatoi; Matthew S Block; Carrie L Langstraat; Gretchen E Glaser; Tri A Dinh; Matthew W Robertson; John K Camoriano; Kristina A Butler; John A Copland; S John Weroha
Journal:  ESMO Open       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.